Equities research analysts forecast that Anthem Inc (NYSE:ANTM) will announce sales of $22.66 billion for the current quarter, according to Zacks. Six analysts have provided estimates for Anthem’s earnings, with the highest sales estimate coming in at $22.96 billion and the lowest estimate coming in at $22.40 billion. Anthem posted sales of $22.32 billion during the same quarter last year, which suggests a positive year-over-year growth rate of 1.5%. The company is expected to issue its next earnings report on Wednesday, April 25th.
On average, analysts expect that Anthem will report full-year sales of $22.66 billion for the current fiscal year, with estimates ranging from $91.02 billion to $92.24 billion. For the next fiscal year, analysts forecast that the company will post sales of $96.70 billion per share, with estimates ranging from $95.31 billion to $97.86 billion. Zacks’ sales averages are an average based on a survey of sell-side research analysts that cover Anthem.
Anthem (NYSE:ANTM) last released its earnings results on Wednesday, January 31st. The company reported $1.29 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.25 by $0.04. The company had revenue of $22.45 billion during the quarter, compared to analysts’ expectations of $22.17 billion. Anthem had a return on equity of 12.29% and a net margin of 4.27%. The business’s revenue was up 4.5% on a year-over-year basis. During the same period in the prior year, the business posted $1.76 EPS.
Several equities analysts have recently commented on the company. Wells Fargo & Co increased their target price on Anthem from $260.00 to $275.00 and gave the company an “outperform” rating in a research note on Thursday, February 1st. Credit Suisse Group reiterated an “outperform” rating and set a $280.00 target price (up from $255.00) on shares of Anthem in a research note on Thursday, February 1st. ValuEngine upgraded Anthem from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Morgan Stanley raised their price objective on Anthem from $247.00 to $266.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 1st. Finally, Royal Bank of Canada restated a “buy” rating on shares of Anthem in a research note on Thursday, January 4th. Four research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $230.80.
In other Anthem news, Chairman Joseph Swedish sold 21,125 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $231.43, for a total value of $4,888,958.75. Following the sale, the chairman now directly owns 87,668 shares of the company’s stock, valued at $20,289,005.24. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, EVP Gloria M. Mccarthy sold 14,429 shares of the stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $229.68, for a total value of $3,314,052.72. Following the completion of the sale, the executive vice president now directly owns 30,667 shares in the company, valued at $7,043,596.56. The disclosure for this sale can be found here. Insiders sold 167,457 shares of company stock worth $39,862,398 over the last ninety days. 0.36% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently modified their holdings of ANTM. Raymond James Financial Services Advisors Inc. increased its position in Anthem by 10.9% in the second quarter. Raymond James Financial Services Advisors Inc. now owns 7,509 shares of the company’s stock worth $1,413,000 after buying an additional 735 shares during the period. Robeco Institutional Asset Management B.V. increased its position in Anthem by 9.8% in the third quarter. Robeco Institutional Asset Management B.V. now owns 492,015 shares of the company’s stock worth $93,421,000 after buying an additional 43,846 shares during the period. Rockefeller Financial Services Inc. increased its position in Anthem by 92.0% in the third quarter. Rockefeller Financial Services Inc. now owns 54,995 shares of the company’s stock worth $10,443,000 after buying an additional 26,355 shares during the period. Farmers & Merchants Trust Co of Chambersburg PA increased its position in Anthem by 10.0% in the third quarter. Farmers & Merchants Trust Co of Chambersburg PA now owns 8,214 shares of the company’s stock worth $1,560,000 after buying an additional 750 shares during the period. Finally, Foster & Motley Inc. acquired a new stake in Anthem in the third quarter worth $386,000. 85.30% of the stock is currently owned by hedge funds and other institutional investors.
Anthem (NYSE:ANTM) opened at $235.02 on Tuesday. The company has a market capitalization of $60,343.85, a P/E ratio of 16.37, a PEG ratio of 1.35 and a beta of 0.83. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.51 and a current ratio of 1.55. Anthem has a one year low of $158.66 and a one year high of $267.95.
Anthem announced that its Board of Directors has authorized a stock buyback program on Thursday, December 7th that authorizes the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase shares of its stock through open market purchases. Shares repurchase programs are usually a sign that the company’s board of directors believes its shares are undervalued.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, March 23rd. Investors of record on Friday, March 9th will be paid a dividend of $0.75 per share. The ex-dividend date is Thursday, March 8th. This is a boost from Anthem’s previous quarterly dividend of $0.70. This represents a $3.00 annualized dividend and a yield of 1.28%. Anthem’s dividend payout ratio (DPR) is 19.50%.
Anthem, Inc is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.